Caricamento...
Raising Gene Therapy for Unmet Medical Needs in Japan
Gene therapy has a complicated history. Some early trials resulted in catastrophes, including subjects’ deaths. In 2003, the world’s first gene therapy product (GTP) was approved in China. More recently, EU and US regulators have successively approved seven GTPs, including chimeric antigen receptor...
Salvato in:
| Pubblicato in: | JMA J |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Japan Medical Association
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930775/ https://ncbi.nlm.nih.gov/pubmed/33681517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31662/jmaj.2018-0040 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|